Wate, Donato C.
HRN: 05-18-07 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/15/2024
06/21/2024
IV
4.5gm LD Then 2.25gm Q8
Q8
Multiple Carbuncle
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes